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SNPping Razor Bumps
Razor bumps (pseudofolliculitis barbae, or PFB) are a common problem in African-
American males, although they are not limited to any ethnic group. PFB is especially vexing
to men in the US military who are required to be closely shaved. Tightly curved hairs seem to
penetrate the skin and induce chronic inflammation. Basic science identified, or rediscovered, the
companion layer in the hair follicle that has a specific hair keratin, K6hf. The companion layer is tightly
connected to the Henle layer of the internal root sheath, and it may guide and stabilize the ascending
hair. An alanine to threonine substitution (a single nucleotide polymorphism, a.k.a. ‘‘a SNP’’) in the 1A a-
helical segment of K6hf has a significant association with PFB (odds ratio 6.1; 95% confidence interval
2.1–17.8). This is independent of the association of curved hair follicles with PFB. How the identification
of this molecular association will lead to new therapies is a challenge for hair biologists. It is an important
example of how molecular defects can be important in common disorders as well as in rare diseases.
J Invest Dermatol 122:652–657, 2004
Hot Hurting Feet Respond to Prostaglandin E1 Analog (Misoprostol)
Erythromelalgia—with its nocturnal paroxysms of painful feet, eased by standing on cold floors or the
use of non-steroidal inflammatory agents—is a well-characterized clinical syndrome with primary
(unknown) and secondary causes. A group from a country with cold winters has been studying the
physiology of erythromelalgia for over a decade, and suggests that increased microvascular shunting in
the skin is an important feature of the disorder. Mrk and co-workers performed a blinded cross-over
placebo-controlled study with oral misoprostol, with satisfactory safety studies and pain reduction. They
report a decreased response to body heating with misoprostol compared with placebo, during a Duvet
stress test to increase central body temperature, designed to mimic sleeping conditions during
the Norwegian winter (mean temperature 0.11C). The heterogeneity of conditions associated with
erythromelalgia should not detract from a potential new therapy for this vexing disorder. J Invest
Dermatol 122:587–593, 2004
Watch the Skin Clock
The skin, like many other tissues, has circadian (Latin for ‘‘almost a
day’’) and ultradian rhythms (operationally defined as 20 or fewer
hours). These rhythms may be driven (and or fixed) by catecho-
lamines and potentially by environmental light. Studying normal
men and women under highly controlled environmental conditions,
Yosipovitch and coauthors showed that neither tape stripping
nor mid-potency (mometasone) or high-potency (clobetasol)
steroid ointments interfered
with circadian rhythms, barrier
function, or blood flow. Low
blood flow in the morning hours
might affect the systemic uptake
of drugs from the epidermis;
in other organ systems detailed
timing of drug administration
has been studied, and it seems
warranted in humans with skin
disease to see if the differences
in basic skin physiology may
affect the pharmacological effi-
cacy of topical agents. J Invest Dermatol 122:824–829, 2004
Superoxide Dismutase Antibodies in
Localized Scleroderma
Autoantibodies can function as a diagnostic aid for a disease and
may also indicate the fundamental pathophysiology associated with a
disorder. Antibodies against Cu/Zn superoxide dismutase (SOD) were
positive in 89% of localized scleroderma patients, and were positive
in all 13 patients with generalized morphea, but were only positive in
15% of patients with classical
autoimmune diseases, including
the autoimmune blistering dis-
eases. The antibodies inhibited
SOD enzymatic activity, and
Nagai and co-workers postulate
that the antibodies can thus
contribute to fibrosis. SOD has
been used in the therapy of other
models of fibrosing disorders,
and there may be therapeutic
implications to these antibody
findings in addition to the diag-
nostic implications. J Invest
Dermatol 122:594–601, 2004
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